nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—Alzheimer's disease	0.503	1	CbGaD
Glipizide—CYP2C9—Donepezil—Alzheimer's disease	0.098	0.373	CbGbCtD
Glipizide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0713	0.271	CbGbCtD
Glipizide—CYP3A4—Donepezil—Alzheimer's disease	0.057	0.217	CbGbCtD
Glipizide—CYP3A4—Galantamine—Alzheimer's disease	0.0367	0.14	CbGbCtD
Glipizide—PPARG—blood vessel—Alzheimer's disease	0.00175	0.136	CbGeAlD
Glipizide—Glyburide—ABCA1—Alzheimer's disease	0.0013	0.427	CrCbGaD
Glipizide—Gliclazide—VEGFA—Alzheimer's disease	0.00123	0.406	CrCbGaD
Glipizide—ABCC8—forebrain—Alzheimer's disease	0.00121	0.094	CbGeAlD
Glipizide—ABCC8—telencephalon—Alzheimer's disease	0.00111	0.0864	CbGeAlD
Glipizide—PPARG—embryo—Alzheimer's disease	0.00104	0.0811	CbGeAlD
Glipizide—PPARG—forebrain—Alzheimer's disease	0.000923	0.0718	CbGeAlD
Glipizide—Eczema—Memantine—Alzheimer's disease	0.00092	0.00554	CcSEcCtD
Glipizide—Hyponatraemia—Donepezil—Alzheimer's disease	0.000915	0.0055	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.000911	0.00548	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000904	0.00544	CcSEcCtD
Glipizide—Eczema—Rivastigmine—Alzheimer's disease	0.000901	0.00542	CcSEcCtD
Glipizide—Libido decreased—Memantine—Alzheimer's disease	0.000892	0.00537	CcSEcCtD
Glipizide—Libido decreased—Rivastigmine—Alzheimer's disease	0.000873	0.00525	CcSEcCtD
Glipizide—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000857	0.00515	CcSEcCtD
Glipizide—Thirst—Rivastigmine—Alzheimer's disease	0.00085	0.00512	CcSEcCtD
Glipizide—Hypoglycaemia—Memantine—Alzheimer's disease	0.000848	0.0051	CcSEcCtD
Glipizide—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000832	0.00501	CcSEcCtD
Glipizide—Hyponatraemia—Memantine—Alzheimer's disease	0.000831	0.005	CcSEcCtD
Glipizide—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000829	0.00499	CcSEcCtD
Glipizide—Diplopia—Memantine—Alzheimer's disease	0.000827	0.00498	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.000827	0.00498	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000821	0.00494	CcSEcCtD
Glipizide—Rhinitis—Galantamine—Alzheimer's disease	0.000815	0.0049	CcSEcCtD
Glipizide—Hepatitis—Galantamine—Alzheimer's disease	0.000813	0.00489	CcSEcCtD
Glipizide—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000813	0.00489	CcSEcCtD
Glipizide—Diplopia—Rivastigmine—Alzheimer's disease	0.000809	0.00487	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000809	0.00487	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000803	0.00483	CcSEcCtD
Glipizide—Migraine—Rivastigmine—Alzheimer's disease	0.000797	0.00479	CcSEcCtD
Glipizide—Visual impairment—Galantamine—Alzheimer's disease	0.000784	0.00471	CcSEcCtD
Glipizide—Eye disorder—Galantamine—Alzheimer's disease	0.00076	0.00457	CcSEcCtD
Glipizide—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000755	0.00454	CcSEcCtD
Glipizide—Flushing—Galantamine—Alzheimer's disease	0.000755	0.00454	CcSEcCtD
Glipizide—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000739	0.00445	CcSEcCtD
Glipizide—Dysuria—Donepezil—Alzheimer's disease	0.000736	0.00443	CcSEcCtD
Glipizide—Arrhythmia—Galantamine—Alzheimer's disease	0.000727	0.00437	CcSEcCtD
Glipizide—KCNJ11—nervous system—Alzheimer's disease	0.000713	0.0554	CbGeAlD
Glipizide—Flatulence—Galantamine—Alzheimer's disease	0.000698	0.0042	CcSEcCtD
Glipizide—Tension—Galantamine—Alzheimer's disease	0.000695	0.00418	CcSEcCtD
Glipizide—Nervousness—Galantamine—Alzheimer's disease	0.000688	0.00414	CcSEcCtD
Glipizide—KCNJ11—central nervous system—Alzheimer's disease	0.000686	0.0533	CbGeAlD
Glipizide—Jaundice—Donepezil—Alzheimer's disease	0.000684	0.00412	CcSEcCtD
Glipizide—Conjunctivitis—Donepezil—Alzheimer's disease	0.000682	0.00411	CcSEcCtD
Glipizide—Muscle spasms—Galantamine—Alzheimer's disease	0.000681	0.00409	CcSEcCtD
Glipizide—Pancytopenia—Memantine—Alzheimer's disease	0.000679	0.00408	CcSEcCtD
Glipizide—Sweating—Donepezil—Alzheimer's disease	0.000673	0.00405	CcSEcCtD
Glipizide—KCNJ11—cerebellum—Alzheimer's disease	0.000671	0.0521	CbGeAlD
Glipizide—Dysuria—Memantine—Alzheimer's disease	0.000669	0.00402	CcSEcCtD
Glipizide—Vision blurred—Galantamine—Alzheimer's disease	0.000667	0.00401	CcSEcCtD
Glipizide—Tremor—Galantamine—Alzheimer's disease	0.000663	0.00399	CcSEcCtD
Glipizide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000657	0.00395	CcSEcCtD
Glipizide—ABCC8—nervous system—Alzheimer's disease	0.000657	0.051	CbGeAlD
Glipizide—Dysuria—Rivastigmine—Alzheimer's disease	0.000654	0.00393	CcSEcCtD
Glipizide—Malaise—Galantamine—Alzheimer's disease	0.000638	0.00384	CcSEcCtD
Glipizide—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000638	0.00384	CcSEcCtD
Glipizide—Vertigo—Galantamine—Alzheimer's disease	0.000636	0.00383	CcSEcCtD
Glipizide—Syncope—Galantamine—Alzheimer's disease	0.000635	0.00382	CcSEcCtD
Glipizide—ABCC8—central nervous system—Alzheimer's disease	0.000632	0.0491	CbGeAlD
Glipizide—Rhinitis—Donepezil—Alzheimer's disease	0.000632	0.0038	CcSEcCtD
Glipizide—Hepatitis—Donepezil—Alzheimer's disease	0.00063	0.00379	CcSEcCtD
Glipizide—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000627	0.00377	CcSEcCtD
Glipizide—Pharyngitis—Donepezil—Alzheimer's disease	0.000626	0.00376	CcSEcCtD
Glipizide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000624	0.00375	CcSEcCtD
Glipizide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000622	0.00374	CcSEcCtD
Glipizide—Conjunctivitis—Memantine—Alzheimer's disease	0.00062	0.00373	CcSEcCtD
Glipizide—ABCC8—cerebellum—Alzheimer's disease	0.000618	0.048	CbGeAlD
Glipizide—Hypertension—Galantamine—Alzheimer's disease	0.000611	0.00368	CcSEcCtD
Glipizide—Visual impairment—Donepezil—Alzheimer's disease	0.000607	0.00365	CcSEcCtD
Glipizide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000606	0.00365	CcSEcCtD
Glipizide—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000603	0.00363	CcSEcCtD
Glipizide—Myalgia—Galantamine—Alzheimer's disease	0.000603	0.00363	CcSEcCtD
Glipizide—Arthralgia—Galantamine—Alzheimer's disease	0.000603	0.00363	CcSEcCtD
Glipizide—Anxiety—Galantamine—Alzheimer's disease	0.000601	0.00361	CcSEcCtD
Glipizide—Sweating—Rivastigmine—Alzheimer's disease	0.000598	0.0036	CcSEcCtD
Glipizide—Discomfort—Galantamine—Alzheimer's disease	0.000596	0.00358	CcSEcCtD
Glipizide—Agranulocytosis—Memantine—Alzheimer's disease	0.000595	0.00358	CcSEcCtD
Glipizide—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00059	0.00355	CcSEcCtD
Glipizide—Confusional state—Galantamine—Alzheimer's disease	0.000583	0.0035	CcSEcCtD
Glipizide—Rhinitis—Memantine—Alzheimer's disease	0.000574	0.00345	CcSEcCtD
Glipizide—Hepatitis—Memantine—Alzheimer's disease	0.000572	0.00344	CcSEcCtD
Glipizide—Hypoaesthesia—Memantine—Alzheimer's disease	0.000569	0.00343	CcSEcCtD
Glipizide—Shock—Galantamine—Alzheimer's disease	0.000568	0.00342	CcSEcCtD
Glipizide—Pharyngitis—Memantine—Alzheimer's disease	0.000568	0.00342	CcSEcCtD
Glipizide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000566	0.0034	CcSEcCtD
Glipizide—Chills—Donepezil—Alzheimer's disease	0.000566	0.0034	CcSEcCtD
Glipizide—Arrhythmia—Donepezil—Alzheimer's disease	0.000563	0.00339	CcSEcCtD
Glipizide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000561	0.00338	CcSEcCtD
Glipizide—Hepatitis—Rivastigmine—Alzheimer's disease	0.00056	0.00337	CcSEcCtD
Glipizide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000559	0.00336	CcSEcCtD
Glipizide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000557	0.00335	CcSEcCtD
Glipizide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000556	0.00334	CcSEcCtD
Glipizide—Visual impairment—Memantine—Alzheimer's disease	0.000551	0.00332	CcSEcCtD
Glipizide—Anorexia—Galantamine—Alzheimer's disease	0.000551	0.00331	CcSEcCtD
Glipizide—Erythema—Donepezil—Alzheimer's disease	0.000549	0.0033	CcSEcCtD
Glipizide—KCNJ11—brain—Alzheimer's disease	0.000545	0.0423	CbGeAlD
Glipizide—Flatulence—Donepezil—Alzheimer's disease	0.000541	0.00325	CcSEcCtD
Glipizide—Visual impairment—Rivastigmine—Alzheimer's disease	0.00054	0.00325	CcSEcCtD
Glipizide—Tension—Donepezil—Alzheimer's disease	0.000538	0.00324	CcSEcCtD
Glipizide—Eye disorder—Memantine—Alzheimer's disease	0.000535	0.00322	CcSEcCtD
Glipizide—Nervousness—Donepezil—Alzheimer's disease	0.000533	0.00321	CcSEcCtD
Glipizide—Flushing—Memantine—Alzheimer's disease	0.000531	0.00319	CcSEcCtD
Glipizide—Muscle spasms—Donepezil—Alzheimer's disease	0.000528	0.00317	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000526	0.00317	CcSEcCtD
Glipizide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000523	0.00315	CcSEcCtD
Glipizide—Insomnia—Galantamine—Alzheimer's disease	0.000523	0.00314	CcSEcCtD
Glipizide—Flushing—Rivastigmine—Alzheimer's disease	0.00052	0.00313	CcSEcCtD
Glipizide—Paraesthesia—Galantamine—Alzheimer's disease	0.000519	0.00312	CcSEcCtD
Glipizide—Vision blurred—Donepezil—Alzheimer's disease	0.000517	0.00311	CcSEcCtD
Glipizide—Tremor—Donepezil—Alzheimer's disease	0.000514	0.00309	CcSEcCtD
Glipizide—Somnolence—Galantamine—Alzheimer's disease	0.000514	0.00309	CcSEcCtD
Glipizide—Chills—Memantine—Alzheimer's disease	0.000513	0.00309	CcSEcCtD
Glipizide—Arrhythmia—Memantine—Alzheimer's disease	0.000511	0.00308	CcSEcCtD
Glipizide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000509	0.00306	CcSEcCtD
Glipizide—Dyspepsia—Galantamine—Alzheimer's disease	0.000509	0.00306	CcSEcCtD
Glipizide—Chlorpropamide—PTGS1—Alzheimer's disease	0.000507	0.167	CrCbGaD
Glipizide—Chills—Rivastigmine—Alzheimer's disease	0.000502	0.00302	CcSEcCtD
Glipizide—Decreased appetite—Galantamine—Alzheimer's disease	0.000502	0.00302	CcSEcCtD
Glipizide—ABCC8—brain—Alzheimer's disease	0.000502	0.039	CbGeAlD
Glipizide—PPARG—nervous system—Alzheimer's disease	0.000501	0.039	CbGeAlD
Glipizide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.0005	0.00301	CcSEcCtD
Glipizide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000499	0.003	CcSEcCtD
Glipizide—Malaise—Donepezil—Alzheimer's disease	0.000495	0.00298	CcSEcCtD
Glipizide—Constipation—Galantamine—Alzheimer's disease	0.000494	0.00297	CcSEcCtD
Glipizide—Vertigo—Donepezil—Alzheimer's disease	0.000493	0.00297	CcSEcCtD
Glipizide—Syncope—Donepezil—Alzheimer's disease	0.000492	0.00296	CcSEcCtD
Glipizide—Flatulence—Memantine—Alzheimer's disease	0.000491	0.00295	CcSEcCtD
Glipizide—Tension—Memantine—Alzheimer's disease	0.000489	0.00294	CcSEcCtD
Glipizide—Erythema—Rivastigmine—Alzheimer's disease	0.000487	0.00293	CcSEcCtD
Glipizide—Nervousness—Memantine—Alzheimer's disease	0.000484	0.00291	CcSEcCtD
Glipizide—PPARG—central nervous system—Alzheimer's disease	0.000483	0.0375	CbGeAlD
Glipizide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000482	0.0029	CcSEcCtD
Glipizide—Flatulence—Rivastigmine—Alzheimer's disease	0.00048	0.00289	CcSEcCtD
Glipizide—Tension—Rivastigmine—Alzheimer's disease	0.000478	0.00288	CcSEcCtD
Glipizide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000476	0.00286	CcSEcCtD
Glipizide—Hypertension—Donepezil—Alzheimer's disease	0.000474	0.00285	CcSEcCtD
Glipizide—Nervousness—Rivastigmine—Alzheimer's disease	0.000473	0.00285	CcSEcCtD
Glipizide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000472	0.00284	CcSEcCtD
Glipizide—Vision blurred—Memantine—Alzheimer's disease	0.000469	0.00282	CcSEcCtD
Glipizide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000469	0.00282	CcSEcCtD
Glipizide—Myalgia—Donepezil—Alzheimer's disease	0.000467	0.00281	CcSEcCtD
Glipizide—Arthralgia—Donepezil—Alzheimer's disease	0.000467	0.00281	CcSEcCtD
Glipizide—Tremor—Memantine—Alzheimer's disease	0.000467	0.00281	CcSEcCtD
Glipizide—Anxiety—Donepezil—Alzheimer's disease	0.000465	0.0028	CcSEcCtD
Glipizide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000462	0.00278	CcSEcCtD
Glipizide—Discomfort—Donepezil—Alzheimer's disease	0.000462	0.00278	CcSEcCtD
Glipizide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000459	0.00276	CcSEcCtD
Glipizide—Abdominal pain—Galantamine—Alzheimer's disease	0.000457	0.00275	CcSEcCtD
Glipizide—Tremor—Rivastigmine—Alzheimer's disease	0.000457	0.00275	CcSEcCtD
Glipizide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000452	0.00272	CcSEcCtD
Glipizide—Confusional state—Donepezil—Alzheimer's disease	0.000452	0.00272	CcSEcCtD
Glipizide—Malaise—Memantine—Alzheimer's disease	0.000449	0.0027	CcSEcCtD
Glipizide—Oedema—Donepezil—Alzheimer's disease	0.000448	0.00269	CcSEcCtD
Glipizide—Vertigo—Memantine—Alzheimer's disease	0.000448	0.00269	CcSEcCtD
Glipizide—Syncope—Memantine—Alzheimer's disease	0.000447	0.00269	CcSEcCtD
Glipizide—Leukopenia—Memantine—Alzheimer's disease	0.000446	0.00268	CcSEcCtD
Glipizide—Shock—Donepezil—Alzheimer's disease	0.000441	0.00265	CcSEcCtD
Glipizide—Malaise—Rivastigmine—Alzheimer's disease	0.000439	0.00264	CcSEcCtD
Glipizide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000438	0.00264	CcSEcCtD
Glipizide—Vertigo—Rivastigmine—Alzheimer's disease	0.000438	0.00263	CcSEcCtD
Glipizide—Loss of consciousness—Memantine—Alzheimer's disease	0.000438	0.00263	CcSEcCtD
Glipizide—Syncope—Rivastigmine—Alzheimer's disease	0.000437	0.00263	CcSEcCtD
Glipizide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000433	0.0026	CcSEcCtD
Glipizide—Hypertension—Memantine—Alzheimer's disease	0.00043	0.00259	CcSEcCtD
Glipizide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000428	0.00258	CcSEcCtD
Glipizide—Anorexia—Donepezil—Alzheimer's disease	0.000427	0.00257	CcSEcCtD
Glipizide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000426	0.00256	CcSEcCtD
Glipizide—Myalgia—Memantine—Alzheimer's disease	0.000424	0.00255	CcSEcCtD
Glipizide—Arthralgia—Memantine—Alzheimer's disease	0.000424	0.00255	CcSEcCtD
Glipizide—Anxiety—Memantine—Alzheimer's disease	0.000423	0.00254	CcSEcCtD
Glipizide—Hypertension—Rivastigmine—Alzheimer's disease	0.000421	0.00253	CcSEcCtD
Glipizide—Discomfort—Memantine—Alzheimer's disease	0.000419	0.00252	CcSEcCtD
Glipizide—Myalgia—Rivastigmine—Alzheimer's disease	0.000415	0.0025	CcSEcCtD
Glipizide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000415	0.0025	CcSEcCtD
Glipizide—Asthenia—Galantamine—Alzheimer's disease	0.000415	0.00249	CcSEcCtD
Glipizide—Anxiety—Rivastigmine—Alzheimer's disease	0.000413	0.00249	CcSEcCtD
Glipizide—Confusional state—Memantine—Alzheimer's disease	0.00041	0.00247	CcSEcCtD
Glipizide—Discomfort—Rivastigmine—Alzheimer's disease	0.00041	0.00247	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000408	0.00245	CcSEcCtD
Glipizide—Oedema—Memantine—Alzheimer's disease	0.000407	0.00245	CcSEcCtD
Glipizide—Insomnia—Donepezil—Alzheimer's disease	0.000405	0.00244	CcSEcCtD
Glipizide—Paraesthesia—Donepezil—Alzheimer's disease	0.000402	0.00242	CcSEcCtD
Glipizide—Confusional state—Rivastigmine—Alzheimer's disease	0.000401	0.00241	CcSEcCtD
Glipizide—Shock—Memantine—Alzheimer's disease	0.0004	0.00241	CcSEcCtD
Glipizide—Dyspnoea—Donepezil—Alzheimer's disease	0.000399	0.0024	CcSEcCtD
Glipizide—Somnolence—Donepezil—Alzheimer's disease	0.000398	0.00239	CcSEcCtD
Glipizide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000398	0.00239	CcSEcCtD
Glipizide—Oedema—Rivastigmine—Alzheimer's disease	0.000398	0.00239	CcSEcCtD
Glipizide—Diarrhoea—Galantamine—Alzheimer's disease	0.000395	0.00238	CcSEcCtD
Glipizide—Dyspepsia—Donepezil—Alzheimer's disease	0.000394	0.00237	CcSEcCtD
Glipizide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000393	0.00236	CcSEcCtD
Glipizide—Shock—Rivastigmine—Alzheimer's disease	0.000391	0.00235	CcSEcCtD
Glipizide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000389	0.00234	CcSEcCtD
Glipizide—Decreased appetite—Donepezil—Alzheimer's disease	0.000389	0.00234	CcSEcCtD
Glipizide—Anorexia—Memantine—Alzheimer's disease	0.000388	0.00233	CcSEcCtD
Glipizide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000387	0.00233	CcSEcCtD
Glipizide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000385	0.00231	CcSEcCtD
Glipizide—PPARG—brain—Alzheimer's disease	0.000383	0.0298	CbGeAlD
Glipizide—Pain—Donepezil—Alzheimer's disease	0.000383	0.0023	CcSEcCtD
Glipizide—Constipation—Donepezil—Alzheimer's disease	0.000383	0.0023	CcSEcCtD
Glipizide—Dizziness—Galantamine—Alzheimer's disease	0.000382	0.0023	CcSEcCtD
Glipizide—Anorexia—Rivastigmine—Alzheimer's disease	0.000379	0.00228	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00037	0.00223	CcSEcCtD
Glipizide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000369	0.00222	CcSEcCtD
Glipizide—Insomnia—Memantine—Alzheimer's disease	0.000368	0.00221	CcSEcCtD
Glipizide—Vomiting—Galantamine—Alzheimer's disease	0.000367	0.00221	CcSEcCtD
Glipizide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000366	0.0022	CcSEcCtD
Glipizide—Paraesthesia—Memantine—Alzheimer's disease	0.000365	0.0022	CcSEcCtD
Glipizide—Rash—Galantamine—Alzheimer's disease	0.000364	0.00219	CcSEcCtD
Glipizide—Dermatitis—Galantamine—Alzheimer's disease	0.000364	0.00219	CcSEcCtD
Glipizide—Dyspnoea—Memantine—Alzheimer's disease	0.000362	0.00218	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000362	0.00218	CcSEcCtD
Glipizide—Headache—Galantamine—Alzheimer's disease	0.000362	0.00218	CcSEcCtD
Glipizide—Somnolence—Memantine—Alzheimer's disease	0.000361	0.00217	CcSEcCtD
Glipizide—Insomnia—Rivastigmine—Alzheimer's disease	0.00036	0.00216	CcSEcCtD
Glipizide—Dyspepsia—Memantine—Alzheimer's disease	0.000358	0.00215	CcSEcCtD
Glipizide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000357	0.00215	CcSEcCtD
Glipizide—Urticaria—Donepezil—Alzheimer's disease	0.000356	0.00214	CcSEcCtD
Glipizide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000355	0.00213	CcSEcCtD
Glipizide—Abdominal pain—Donepezil—Alzheimer's disease	0.000354	0.00213	CcSEcCtD
Glipizide—Somnolence—Rivastigmine—Alzheimer's disease	0.000354	0.00213	CcSEcCtD
Glipizide—Decreased appetite—Memantine—Alzheimer's disease	0.000353	0.00213	CcSEcCtD
Glipizide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000351	0.00211	CcSEcCtD
Glipizide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00035	0.00211	CcSEcCtD
Glipizide—Pain—Memantine—Alzheimer's disease	0.000348	0.00209	CcSEcCtD
Glipizide—Constipation—Memantine—Alzheimer's disease	0.000348	0.00209	CcSEcCtD
Glipizide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000346	0.00208	CcSEcCtD
Glipizide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000343	0.00207	CcSEcCtD
Glipizide—Nausea—Galantamine—Alzheimer's disease	0.000343	0.00206	CcSEcCtD
Glipizide—Pain—Rivastigmine—Alzheimer's disease	0.00034	0.00205	CcSEcCtD
Glipizide—Constipation—Rivastigmine—Alzheimer's disease	0.00034	0.00205	CcSEcCtD
Glipizide—Feeling abnormal—Memantine—Alzheimer's disease	0.000335	0.00202	CcSEcCtD
Glipizide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000332	0.002	CcSEcCtD
Glipizide—Hypersensitivity—Donepezil—Alzheimer's disease	0.00033	0.00198	CcSEcCtD
Glipizide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000328	0.00197	CcSEcCtD
Glipizide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000325	0.00196	CcSEcCtD
Glipizide—Urticaria—Memantine—Alzheimer's disease	0.000323	0.00194	CcSEcCtD
Glipizide—Abdominal pain—Memantine—Alzheimer's disease	0.000321	0.00193	CcSEcCtD
Glipizide—Asthenia—Donepezil—Alzheimer's disease	0.000321	0.00193	CcSEcCtD
Glipizide—Pruritus—Donepezil—Alzheimer's disease	0.000317	0.00191	CcSEcCtD
Glipizide—Urticaria—Rivastigmine—Alzheimer's disease	0.000316	0.0019	CcSEcCtD
Glipizide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000314	0.00189	CcSEcCtD
Glipizide—Diarrhoea—Donepezil—Alzheimer's disease	0.000306	0.00184	CcSEcCtD
Glipizide—Hypersensitivity—Memantine—Alzheimer's disease	0.0003	0.0018	CcSEcCtD
Glipizide—Dizziness—Donepezil—Alzheimer's disease	0.000296	0.00178	CcSEcCtD
Glipizide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000293	0.00176	CcSEcCtD
Glipizide—Asthenia—Memantine—Alzheimer's disease	0.000292	0.00175	CcSEcCtD
Glipizide—Pruritus—Memantine—Alzheimer's disease	0.000288	0.00173	CcSEcCtD
Glipizide—Asthenia—Rivastigmine—Alzheimer's disease	0.000285	0.00172	CcSEcCtD
Glipizide—Vomiting—Donepezil—Alzheimer's disease	0.000285	0.00171	CcSEcCtD
Glipizide—Rash—Donepezil—Alzheimer's disease	0.000282	0.0017	CcSEcCtD
Glipizide—Dermatitis—Donepezil—Alzheimer's disease	0.000282	0.0017	CcSEcCtD
Glipizide—Pruritus—Rivastigmine—Alzheimer's disease	0.000281	0.00169	CcSEcCtD
Glipizide—Headache—Donepezil—Alzheimer's disease	0.000281	0.00169	CcSEcCtD
Glipizide—Diarrhoea—Memantine—Alzheimer's disease	0.000278	0.00167	CcSEcCtD
Glipizide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000272	0.00164	CcSEcCtD
Glipizide—Dizziness—Memantine—Alzheimer's disease	0.000269	0.00162	CcSEcCtD
Glipizide—Nausea—Donepezil—Alzheimer's disease	0.000266	0.0016	CcSEcCtD
Glipizide—Dizziness—Rivastigmine—Alzheimer's disease	0.000263	0.00158	CcSEcCtD
Glipizide—Vomiting—Memantine—Alzheimer's disease	0.000259	0.00156	CcSEcCtD
Glipizide—Rash—Memantine—Alzheimer's disease	0.000256	0.00154	CcSEcCtD
Glipizide—Dermatitis—Memantine—Alzheimer's disease	0.000256	0.00154	CcSEcCtD
Glipizide—Headache—Memantine—Alzheimer's disease	0.000255	0.00153	CcSEcCtD
Glipizide—Vomiting—Rivastigmine—Alzheimer's disease	0.000253	0.00152	CcSEcCtD
Glipizide—Rash—Rivastigmine—Alzheimer's disease	0.000251	0.00151	CcSEcCtD
Glipizide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000251	0.00151	CcSEcCtD
Glipizide—Headache—Rivastigmine—Alzheimer's disease	0.000249	0.0015	CcSEcCtD
Glipizide—Nausea—Memantine—Alzheimer's disease	0.000242	0.00145	CcSEcCtD
Glipizide—Nausea—Rivastigmine—Alzheimer's disease	0.000236	0.00142	CcSEcCtD
Glipizide—CYP3A4—nervous system—Alzheimer's disease	0.000224	0.0174	CbGeAlD
Glipizide—CYP3A4—central nervous system—Alzheimer's disease	0.000215	0.0167	CbGeAlD
Glipizide—KCNJ11—Metabolism—ATP5A1—Alzheimer's disease	9.73e-05	0.00188	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IGF1—Alzheimer's disease	9.68e-05	0.00187	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—PRKCG—Alzheimer's disease	9.59e-05	0.00185	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLD3—Alzheimer's disease	9.58e-05	0.00185	CbGpPWpGaD
Glipizide—PPARG—Metabolism—DHCR24—Alzheimer's disease	9.49e-05	0.00184	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLD3—Alzheimer's disease	9.29e-05	0.0018	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	9.26e-05	0.00179	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HSD17B10—Alzheimer's disease	9.18e-05	0.00178	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	9.14e-05	0.00177	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	8.99e-05	0.00174	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CALM1—Alzheimer's disease	8.91e-05	0.00172	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HSD17B10—Alzheimer's disease	8.9e-05	0.00172	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.9e-05	0.00172	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—TNF—Alzheimer's disease	8.89e-05	0.00172	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	8.87e-05	0.00172	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.85e-05	0.00171	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP46A1—Alzheimer's disease	8.84e-05	0.00171	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PRNP—Alzheimer's disease	8.83e-05	0.00171	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—Alzheimer's disease	8.82e-05	0.00171	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CALM1—Alzheimer's disease	8.64e-05	0.00167	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP46A1—Alzheimer's disease	8.57e-05	0.00166	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PSEN2—Alzheimer's disease	8.55e-05	0.00165	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ND1—Alzheimer's disease	8.53e-05	0.00165	CbGpPWpGaD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—AKT1—Alzheimer's disease	8.4e-05	0.00162	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ND1—Alzheimer's disease	8.28e-05	0.0016	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—LEP—Alzheimer's disease	8.27e-05	0.0016	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Alzheimer's disease	8.24e-05	0.00159	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	8.14e-05	0.00157	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA4—Alzheimer's disease	8.07e-05	0.00156	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.89e-05	0.00153	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	7.85e-05	0.00152	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IAPP—Alzheimer's disease	7.82e-05	0.00151	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—NOS2—Alzheimer's disease	7.7e-05	0.00149	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.66e-05	0.00148	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CREB1—Alzheimer's disease	7.62e-05	0.00147	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GAPDHS—Alzheimer's disease	7.59e-05	0.00147	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.51e-05	0.00145	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CREB1—Alzheimer's disease	7.39e-05	0.00143	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.25e-05	0.0014	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ATP5A1—Alzheimer's disease	7.19e-05	0.00139	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—GSK3B—Alzheimer's disease	7.16e-05	0.00138	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—CREB1—Alzheimer's disease	7.1e-05	0.00137	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLD3—Alzheimer's disease	6.86e-05	0.00133	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.86e-05	0.00133	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.78e-05	0.00131	CbGpPWpGaD
Glipizide—PPARG—SREBP signalling—AKT1—Alzheimer's disease	6.7e-05	0.0013	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—TFAM—Alzheimer's disease	6.69e-05	0.00129	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HSD17B10—Alzheimer's disease	6.58e-05	0.00127	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—DLG4—Alzheimer's disease	6.53e-05	0.00126	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.43e-05	0.00124	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—GRIN2B—Alzheimer's disease	6.39e-05	0.00123	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	6.35e-05	0.00123	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP46A1—Alzheimer's disease	6.33e-05	0.00122	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.22e-05	0.0012	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	6.17e-05	0.00119	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ND1—Alzheimer's disease	6.12e-05	0.00118	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	6.05e-05	0.00117	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.98e-05	0.00116	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.96e-05	0.00115	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TGFB1—Alzheimer's disease	5.8e-05	0.00112	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ADAM10—Alzheimer's disease	5.76e-05	0.00111	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	5.67e-05	0.0011	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TPI1—Alzheimer's disease	5.5e-05	0.00106	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CHAT—Alzheimer's disease	5.5e-05	0.00106	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.47e-05	0.00106	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—Alzheimer's disease	5.42e-05	0.00105	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	5.37e-05	0.00104	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CHAT—Alzheimer's disease	5.33e-05	0.00103	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TPI1—Alzheimer's disease	5.33e-05	0.00103	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PPARGC1A—Alzheimer's disease	5.28e-05	0.00102	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MAOB—Alzheimer's disease	5.27e-05	0.00102	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	5.24e-05	0.00101	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MAOB—Alzheimer's disease	5.11e-05	0.000989	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GAPDH—Alzheimer's disease	5.08e-05	0.000981	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GAPDH—Alzheimer's disease	4.92e-05	0.000952	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—A2M—Alzheimer's disease	4.9e-05	0.000948	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—MAPK8—Alzheimer's disease	4.83e-05	0.000935	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—LPL—Alzheimer's disease	4.8e-05	0.000929	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MEF2C—Alzheimer's disease	4.76e-05	0.000921	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—A2M—Alzheimer's disease	4.75e-05	0.000919	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.71e-05	0.000911	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IL6—Alzheimer's disease	4.37e-05	0.000846	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.29e-05	0.00083	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ACHE—Alzheimer's disease	4.26e-05	0.000825	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—INPP5D—Alzheimer's disease	4.22e-05	0.000815	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ACHE—Alzheimer's disease	4.14e-05	0.0008	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—INPP5D—Alzheimer's disease	4.09e-05	0.00079	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—ESR1—Alzheimer's disease	4.08e-05	0.00079	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.07e-05	0.000786	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—LEP—Alzheimer's disease	4.03e-05	0.000779	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—EIF2S1—Alzheimer's disease	4.03e-05	0.000779	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS1—Alzheimer's disease	4e-05	0.000773	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ENO1—Alzheimer's disease	4e-05	0.000773	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.99e-05	0.000771	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.95e-05	0.000763	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TPI1—Alzheimer's disease	3.94e-05	0.000762	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CHAT—Alzheimer's disease	3.94e-05	0.000762	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.93e-05	0.000761	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2D6—Alzheimer's disease	3.92e-05	0.000758	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS1—Alzheimer's disease	3.87e-05	0.000749	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ENO1—Alzheimer's disease	3.87e-05	0.000749	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2D6—Alzheimer's disease	3.8e-05	0.000735	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MAOB—Alzheimer's disease	3.78e-05	0.000731	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NOTCH1—Alzheimer's disease	3.72e-05	0.000719	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—BCHE—Alzheimer's disease	3.71e-05	0.000718	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GAPDH—Alzheimer's disease	3.64e-05	0.000703	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—BCHE—Alzheimer's disease	3.6e-05	0.000697	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.6e-05	0.000695	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.56e-05	0.000689	CbGpPWpGaD
Glipizide—PPARG—Metabolism—A2M—Alzheimer's disease	3.51e-05	0.000679	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLCB1—Alzheimer's disease	3.51e-05	0.000678	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	3.5e-05	0.000676	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—GSK3B—Alzheimer's disease	3.49e-05	0.000674	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CREB1—Alzheimer's disease	3.46e-05	0.000669	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—INS—Alzheimer's disease	3.44e-05	0.000665	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLCB1—Alzheimer's disease	3.4e-05	0.000657	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCA1—Alzheimer's disease	3.4e-05	0.000657	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—Alzheimer's disease	3.37e-05	0.000652	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCA1—Alzheimer's disease	3.29e-05	0.000637	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.26e-05	0.00063	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—Alzheimer's disease	3.09e-05	0.000597	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ACHE—Alzheimer's disease	3.06e-05	0.000591	CbGpPWpGaD
Glipizide—PPARG—Metabolism—INPP5D—Alzheimer's disease	3.02e-05	0.000584	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.97e-05	0.000575	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARGC1A—Alzheimer's disease	2.93e-05	0.000566	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMOX1—Alzheimer's disease	2.92e-05	0.000564	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.9e-05	0.000562	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS1—Alzheimer's disease	2.86e-05	0.000554	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ENO1—Alzheimer's disease	2.86e-05	0.000554	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARGC1A—Alzheimer's disease	2.84e-05	0.000549	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMOX1—Alzheimer's disease	2.83e-05	0.000547	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2D6—Alzheimer's disease	2.81e-05	0.000543	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.79e-05	0.00054	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—LPL—Alzheimer's disease	2.67e-05	0.000516	CbGpPWpGaD
Glipizide—PPARG—Metabolism—BCHE—Alzheimer's disease	2.66e-05	0.000515	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.65e-05	0.000512	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—LPL—Alzheimer's disease	2.59e-05	0.0005	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.53e-05	0.000489	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.53e-05	0.000489	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLCB1—Alzheimer's disease	2.51e-05	0.000486	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.5e-05	0.000483	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.46e-05	0.000477	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCA1—Alzheimer's disease	2.43e-05	0.000471	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.42e-05	0.000469	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—Alzheimer's disease	2.4e-05	0.000464	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.37e-05	0.000458	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.33e-05	0.000451	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—Alzheimer's disease	2.33e-05	0.00045	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.31e-05	0.000446	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ND1—Alzheimer's disease	2.25e-05	0.000436	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CALM1—Alzheimer's disease	2.24e-05	0.000434	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—Alzheimer's disease	2.23e-05	0.000432	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CAV1—Alzheimer's disease	2.21e-05	0.000428	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.2e-05	0.000426	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CALM1—Alzheimer's disease	2.17e-05	0.000421	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—Alzheimer's disease	2.17e-05	0.00042	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—Alzheimer's disease	2.17e-05	0.000419	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CAV1—Alzheimer's disease	2.15e-05	0.000415	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARGC1A—Alzheimer's disease	2.1e-05	0.000406	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—Alzheimer's disease	2.09e-05	0.000404	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.01e-05	0.000389	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—Alzheimer's disease	1.99e-05	0.000386	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—Alzheimer's disease	1.97e-05	0.00038	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.96e-05	0.000379	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—Alzheimer's disease	1.95e-05	0.000376	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LPL—Alzheimer's disease	1.91e-05	0.000369	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—INS—Alzheimer's disease	1.91e-05	0.000369	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH1—Alzheimer's disease	1.9e-05	0.000368	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—Alzheimer's disease	1.89e-05	0.000365	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—Alzheimer's disease	1.86e-05	0.00036	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—INS—Alzheimer's disease	1.85e-05	0.000358	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.84e-05	0.000356	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.75e-05	0.000338	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.74e-05	0.000336	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—Alzheimer's disease	1.72e-05	0.000333	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—Alzheimer's disease	1.67e-05	0.000324	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.67e-05	0.000322	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—Alzheimer's disease	1.62e-05	0.000314	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CALM1—Alzheimer's disease	1.61e-05	0.000311	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—Alzheimer's disease	1.6e-05	0.00031	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.6e-05	0.000309	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAV1—Alzheimer's disease	1.59e-05	0.000307	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.58e-05	0.000306	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.54e-05	0.000297	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—Alzheimer's disease	1.53e-05	0.000296	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—Alzheimer's disease	1.5e-05	0.000291	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.49e-05	0.000287	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—Alzheimer's disease	1.48e-05	0.000287	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.45e-05	0.000281	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.45e-05	0.000281	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.39e-05	0.000269	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—Alzheimer's disease	1.39e-05	0.000268	CbGpPWpGaD
Glipizide—PPARG—Metabolism—INS—Alzheimer's disease	1.37e-05	0.000265	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.34e-05	0.000259	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.32e-05	0.000256	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.31e-05	0.000254	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.29e-05	0.00025	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—Alzheimer's disease	1.2e-05	0.000232	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.15e-05	0.000223	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.13e-05	0.000218	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.11e-05	0.000215	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—Alzheimer's disease	1.1e-05	0.000212	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.05e-05	0.000204	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.05e-05	0.000204	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.03e-05	0.0002	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	9.8e-06	0.00019	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.57e-06	0.000185	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.57e-06	0.000185	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	9.25e-06	0.000179	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.18e-06	0.000177	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.07e-06	0.000175	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	8.97e-06	0.000173	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.83e-06	0.000171	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.53e-06	0.000165	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	7.73e-06	0.000149	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—Alzheimer's disease	7.7e-06	0.000149	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	7.69e-06	0.000149	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—Alzheimer's disease	7.46e-06	0.000144	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.42e-06	0.000144	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.34e-06	0.000142	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—Alzheimer's disease	7.09e-06	0.000137	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPL—Alzheimer's disease	7.04e-06	0.000136	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.96e-06	0.000134	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.96e-06	0.000134	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.82e-06	0.000132	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.47e-06	0.000125	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	6.34e-06	0.000123	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.1e-06	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	5.92e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.91e-06	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—Alzheimer's disease	5.9e-06	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	5.84e-06	0.000113	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—Alzheimer's disease	5.52e-06	0.000107	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	5.14e-06	9.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.1e-06	9.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.07e-06	9.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—INS—Alzheimer's disease	5.04e-06	9.74e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.64e-06	8.97e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	4.42e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.18e-06	8.08e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	4.04e-06	7.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.9e-06	7.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.89e-06	7.52e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.85e-06	7.45e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.39e-06	6.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—INS—Alzheimer's disease	3.32e-06	6.43e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.91e-06	5.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.67e-06	5.15e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.03e-06	3.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.34e-06	2.59e-05	CbGpPWpGaD
